Showing 221 - 240 results of 871 for search '(( significant sex decrease ) OR ( significant decrease decrease ))~', query time: 0.40s Refine Results
  1. 221

    Number of visits per clinic type, 2013-2015. by Jacob Dreiher (14856863)

    Published 2025
    “…During PE, statistically significant longer waiting times were found for surgery (+1.0 day) and imaging (+1.1 days), while a 2.4 days decrease was noted in pediatrics, controlled for age, sex, ethnicity and the daily number of visits. …”
  2. 222
  3. 223

    Minimal dataset. by Jennifer M. Kwan (3350321)

    Published 2024
    “…In a multivariable analysis, dual ICI therapy (hazard ratio [HR] 1.23, confidence interval [CI] 1.04–1.45), age (HR 1.01, CI 1.00–1.01), male sex (HR 1.18, CI 1.02–1.36), prior arrhythmia (HR 1.22, CI 1.03–1.43), lung cancer (HR 1.17, CI 1.01–1.37), and central nervous system (CNS) malignancy (HR 1.23, CI 1.02–1.47), were independently associated with increased ACE. …”
  4. 224
  5. 225

    Scatterplots of respiratory rate and age by sex. by Ina-Maria Rückert-Eheberg (2824901)

    Published 2025
    “…<div><p>Objective</p><p>The aim of the study was to derive median age- and sex-specific respiratory rates in a population-based sample of adults and to identify disease and lifestyle factors associated with elevated respiratory rates.…”
  6. 226

    Data. by Michael C. Payne (2664379)

    Published 2025
    “…Using a generalized estimating equation model that accounted for age, sex, bednet use, and sentinel site, we found no significant difference in the effectiveness of the two treatment approaches (p = 0.845 for Mf and p = 0.332 for CFA). …”
  7. 227
  8. 228
  9. 229
  10. 230

    Trends in ESR per survey round by age group. by Alex Daama (18351052)

    Published 2024
    “…Targeted efforts for counseling focusing on married men, men who had multiple sex partners, and men with lower levels of education may decrease ESR.…”
  11. 231
  12. 232
  13. 233

    Study flow chart. by Raymond Atwine (18574812)

    Published 2025
    “…The risk of ADCs increased from stage 2 (OR: 0.46, p-value: 0.03; 95% CI: 0.23–0.91) to stage 3 (OR: 1.13; p-value: 0.66; 95% CI: 0.65–1.97) but this was not statistically significant. The risk of ADCs decreased with increasing ART duration (<i>P</i> value < 0.05).…”
  14. 234

    Bar graph showing proportion of NADCs. by Raymond Atwine (18574812)

    Published 2025
    “…The risk of ADCs increased from stage 2 (OR: 0.46, p-value: 0.03; 95% CI: 0.23–0.91) to stage 3 (OR: 1.13; p-value: 0.66; 95% CI: 0.65–1.97) but this was not statistically significant. The risk of ADCs decreased with increasing ART duration (<i>P</i> value < 0.05).…”
  15. 235

    Baseline characteristics of study participants. by Raymond Atwine (18574812)

    Published 2025
    “…The risk of ADCs increased from stage 2 (OR: 0.46, p-value: 0.03; 95% CI: 0.23–0.91) to stage 3 (OR: 1.13; p-value: 0.66; 95% CI: 0.65–1.97) but this was not statistically significant. The risk of ADCs decreased with increasing ART duration (<i>P</i> value < 0.05).…”
  16. 236
  17. 237
  18. 238
  19. 239
  20. 240